Mcl-1 determines the Bax dependency of Nbk/Bik-induced apoptosis

Journal of Cell Biology

Volumn 179, Issue 4, 2007, Pages 701-715

  Gillissen, Bernhard ^a   Essmann, Frank ^c   Hemmati, Philipp G ^a   Richter, Antje ^a   Richter, Anja ^a   Öztop, Ilker ^a   Chinnadurai, Govindaswamy ^d   Dörken, Bernd ^a,b   Daniel, Peter T ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BH3 PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN MCL 1; PROTEIN NBK BIK; PROTEIN PUMA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG DESIGN; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ADENOVIRIDAE; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BENZIMIDAZOLES; CARBOCYANINES; CELL LINE; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; CYTOCHROMES C; FLUORESCENT DYES; HCT116 CELLS; HUMANS; KIDNEY; MALE; MEMBRANE PROTEINS; MITOCHONDRIA; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSGENES;

EID: 36349021416     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200703040     Document Type: Article

References (50)

1. Bargou, R.C., P.T. Daniel, M.Y. Mapara, K. Bommert, C. Wagener, B. Kallinich, H.D. Royer, and B. Dorken. 1995. Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis. Int. J. Cancer. 60:854-859.
2. Boyd, J.M., G.J. Gallo, B. Elangovan, A.B. Houghton, S. Malstrom, B.J. Avery, R.G. Ebb, T. Subramanian, T. Chittenden, R.J. Lutz, et al. 1995. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene. 11:1921-1928.
3. Cartron, P.F., P. Juin, L. Oliver, S. Martin, K. Meflah, and F.M. Vallette. 2003. Nonredundant role of Bax and Bak in Bid-mediated apoptosis. Mol. Cell. Biol. 23:4701-4712.
4. Cartron, P.F., T. Gallenne, G. Bougras, F. Gautier, F. Manero, P. Vusio, K. Meflah, F.M. Vallette, and P. Juin. 2004. The first alpha helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and PUMA. Mol. Cell. 16:807-818.
5. Castells, A., Y. Ino, D.N. Louis, V. Ramesh, J.F. Gusella, and A.K. Rustgi. 1999. Mapping of a target region of allelic loss to a 0.5-cM interval on chromosome 22q13 in human colorectal cancer. Gastroenterology. 117:831-837.
6. Chandra, D., G. Choy, P.T. Daniel, and D.G. Tang. 2005. Bax-dependent regulation of Bak by voltage-dependent anion channel 2. J. Biol. Chem. 280:19051-19061.
7. Chen, L., S.N. Willis, A. Wei, B.J. Smith, J.I. Fletcher, M.G. Hinds, P.M. Colman, C.L. Day, J.M. Adams, and D.C. Huang. 2005. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell. 17:393-403.
8. Cheng, E.H., T.V. Sheiko, J.K. Fisher, W.J. Craigen, and S.J. Korsmeyer. 2003. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science. 301:513-517.
9. Cory, S., D.C. Huang, and J.M. Adams. 2003. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene. 22:8590-8607.
10. Daniel, P.T., K.T. Pun, S. Ritschel, I. Sturm, J. Holler, B. Dorken, and R. Brown. 1999. Expression of the death gene Bik/Nbk promotes sensitivity to drug-induced apoptosis in corticosteroid-resistant T-cell lymphoma and prevents tumor growth in severe combined immunodeficient mice. Blood. 94:1100-1107.
11. Dansen, T., J. Whitfield, F. Rostker, L. Brown-Swigart, and G. Evan. 2006. Specific requirement for Bax, not Bak, in Myc-induced apoptosis and tumor suppression in vivo. J. Biol. Chem. 281:10890-10895.
12. Desagher, S., A. Osen-Sand, A. Nichols, R. Eskes, S. Montessuit, S. Lauper, K. Maundrell, B. Antonsson, and J.C. Martinou. 1999. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 144:891-901.
13. Elangovan, B., and G. Chinnadurai. 1997. Functional dissection of the proapoptotic protein Bik. Heterodimerization with anti-apoptosis proteins is insufficient for induction of cell death. J. Biol. Chem. 272:24494-24498.
14. Germain, M., J.P. Mathai, and G.C. Shore. 2002. BH3-only BIK functions at the endoplasmic reticulum to stimulate cytochrome c release from mitochondria. J. Biol. Chem. 277:18053-18060.
15. Germain, M., J.P. Mathai, H.M. McBride, and G.C. Shore. 2005. Endoplasmic reticulum BIK initiates DRP1-regulated remodelling of mitochondrial cristae during apoptosis. EMBO J. 24:1546-1556.
16. Gillissen, B., F. Essmann, V. Graupner, L. Starck, S. Radetzki, B. Dorken, K. Schulze-Osthoff, and P.T. Daniel. 2003. Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway. EMBO J. 22:3580-3590.
17. Han, J., P. Sabbatini, and E. White. 1996. Induction of apoptosis by human Nbk/ Bik, a BH3-containing protein that interacts with E1B 19K. Mol. Cell. Biol. 16:5857-5864.
18. Hemmati, P.G., B. Gillissen, C. von Haefen, J. Wendt, L. Starck, D. Guner, B. Dorken, and P.T. Daniel. 2002. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis. Oncogene. 21:3149-3161.
19. Hemmati, P.G., D. Guner, B. Gillissen, J. Wendt, C. von Haefen, G. Chinnadurai, B. Dorken, and P.T. Daniel. 2006. Bak functionally complements for loss of Bax during p14ARF-induced mitochondrial apoptosis in human cancer cells. Oncogene. 25:6582-6594.
20. Karbowski, M., Y.J. Lee, B. Gaume, S.Y. Jeong, S. Frank, A. Nechushtan, A. Santel, M. Fuller, C.L. Smith, and R.J. Youle. 2002. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J. Cell Biol. 159:931-938.
21. Korsmeyer, S.J., J.R. Shutter, D.J. Veis, D.E. Merry, and Z.N. Oltvai. 1993. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol. 4:327-332.
22. Kuwana, T., L. Bouchier-Hayes, J.E. Chipuk, C. Bonzon, B.A. Sullivan, D.R. Green, and D.D. Newmeyer. 2005. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol. Cell. 17:525-535.
23. Letai, A., M.C. Bassik, L.D. Walensky, M.D. Sorcinelli, S. Weiler, and S.J. Korsmeyer. 2002. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell. 2:183-192.
24. Lindenboim, L., S. Kringel, T. Braun, C. Borner, and R. Stein. 2005. Bak but not Bax is essential for Bcl-xS-induced apoptosis. Cell Death Differ. 12:713-723.
25. Mathai, J.P., M. Germain, R.C. Marcellus, and G.C. Shore. 2002. Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53. Oncogene. 21:2534-2544.
26. Mathai, J.P., M. Germain, and G.C. Shore. 2005. BH3-only BIK regulates BAX,BAK-dependent release of Ca2+ from endoplasmic reticulum stores and mitochondrial apoptosis during stress-induced cell death. J. Biol. Chem. 280:23829-23836.
27. Mei, Y., W. Du, Y. Yang, and M. Wu. 2005. Puma(*)Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1. Oncogene. 24:7224-7237.
28. Nechushtan, A., C.L. Smith, I. Lamensdorf, S.H. Yoon, and R.J. Youle. 2001. Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis. J. Cell Biol. 153:1265-1276.
29. Nijhawan, D., M. Fang, E. Traer, Q. Zhong, W. Gao, F. Du, and X. Wang. 2003. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev. 17:1475-1486.
30. Oppermann, M., C.C. Geilen, L.F. Fecker, B. Gillissen, P.T. Daniel, and J. Eberle. 2005. Caspase-independent induction of apoptosis in human melanoma cells by the proapoptotic Bcl-2-related protein Nbk/Bik. Oncogene. 24:7369-7380.
31. Strasser, A., A.W. Harris, M.L. Bath, and S. Cory. 1990. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature. 348:331-333.
32. Sturm, I., H. Petrowsky, R. Volz, M. Lorenz, S. Radetzki, T. Hillebrand, G. Wolff, S. Hauptmann, B. Dorken, and P.T. Daniel. 2001. Analysis of p53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: high BAX and p16(ink4a/CDKN2) identifies patients with good prognosis. J. Clin. Oncol. 19:2272-2281.
33. Sturm, I., C. Stephan, B. Gillissen, R. Siebert, M. Janz, S. Radetzki, K. Jung, S. Loening, B. Dorken, and P.T. Daniel. 2006. Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma. Cell Death Differ. 13:619-627.
34. Tagawa, H., S. Karnan, R. Suzuki, K. Matsuo, X. Zhang, A. Ota, Y. Morishima, S. Nakamura, and M. Seto. 2005. Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene. 24:1348-1358.
35. Theodorakis, P., E. Lomonosova, and G. Chinnadurai. 2002. Critical requirement of BAX for manifestation of apoptosis induced by multiple stimuli in human epithelial cancer cells. Cancer Res. 62:3373-3376.
36. Tong, Y., Q. Yang, C. Vater, L.K. Venkatesh, D. Custeau, T. Chittenden, G. Chinnadurai, and H. Gourdeau. 2001. The pro-apoptotic protein, Bik, exhibits potent antitumor activity that is dependent on its BH3 domain. Mol. Cancer Ther. 1:95-102.
37. van Delft, M.F., and D.C. Huang. 2006. How the Bcl-2 family of proteins interact to regulate apoptosis. Cell Res. 16:203-213.
38. Verma, S., L.J. Zhao, and G. Chinnadurai. 2001. Phosphorylation of the proapoptotic protein BIK: mapping of phosphorylation sites and effect on apoptosis. J. Biol. Chem. 276:4671-4676.
39. von Haefen, C., T. Wieder, B. Gillissen, L. Starck, V. Graupner, B. Dorken, and P.T. Daniel. 2002. Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells. Oncogene. 21:4009-4019.
40. von Haefen, C., T. Wieder, F. Essmann, K. Schulze-Osthoff, B. Dorken, and P.T. Daniel. 2003. Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop. Oncogene. 22:2236-2247.
41. von Haefen, C., B. Gillissen, P.G. Hemmati, J. Wendt, D. Guner, A. Mrozek, C. Belka, B. Dorken, and P.T. Daniel. 2004. Multidomain Bcl-2 homolog Bax but not Bak mediates synergistic induction of apoptosis by TRAIL and 5-FU through the mitochondrial apoptosis pathway. Oncogene. 23:8320-8332.
42. Wei, M.C., T. Lindsten, V.K. Mootha, S. Weiler, A. Gross, M. Ashiya, C.B. Thompson, and S.J. Korsmeyer. 2000. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14:2060-2071.
43. Willis, S.N., and J.M. Adams. 2005. Life in the balance: how BH3-only proteins induce apoptosis. Curr. Opin. Cell Biol. 17:617-625.
44. Willis, S.N., L. Chen, G. Dewson, A. Wei, E. Naik, J.I. Fletcher, J.M. Adams, and D.C. Huang. 2005. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 19:1294-1305.
45. Willis, S.N., J.I. Fletcher, T. Kaufmann, M.F. van Delft, L. Chen, P.E. Czabotar, H. Ierino, E.F. Lee, W.D. Fairlie, P. Bouillet, et al. 2007. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science. 315:856-859.
46. Yin, C., C.M. Knudson, S.J. Korsmeyer, and T. Van Dyke. 1997. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature. 385:637-640.
47. Yu, J., Z. Wang, K.W. Kinzler, B. Vogelstein, and L. Zhang. 2003. PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc. Natl. Acad. Sci. USA. 100:1931-1936.
48. Zantl, N., G. Weirich, H. Zall, B.M. Seiffert, S.F. Fischer, S. Kirschnek, C. Hartmann, R.M. Fritsch, B. Gillissen, P.T. Daniel, and G. Hacker. 2007. Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance. Oncogene. 26:7038-7048.
49. Zhang, L., J. Yu, B.H. Park, K.W. Kinzler, and B. Vogelstein. 2000. Role of BAX in the apoptotic response to anticancer agents. Science. 290:989-992.
50. Zhong, Q., W. Gao, F. Du, and X. Wang. 2005. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell. 121:1085-1095.